[Retracted] Expression Level and Clinical Significance of AK021443 in Non-Small-Cell Lung Carcinoma

Figure 2

Subgroup analyses on potential factors influencing OS in NSCLC. (a, b) Overall survival in poorly differentiated (a) or well-differentiated NSCLC patients (b). (c, d) Overall survival in stage I + II (c) or stage III + IV NSCLC patients (d). (e, f) Overall survival in lymphatic metastatic (e) or nonmetastatic NSCLC patients (f).

(a)

(b)

(c)

(d)

(e)

(f)